Raymond James & Associates Embecta Corp. Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Embecta Corp. stock. As of the latest transaction made, Raymond James & Associates holds 194,834 shares of EMBC stock, worth $2.79 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
194,834
Previous 198,330
1.76%
Holding current value
$2.79 Million
Previous $2.48 Million
10.81%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding EMBC
# of Institutions
407Shares Held
52.4MCall Options Held
120KPut Options Held
66.8K-
Black Rock Inc. New York, NY9.19MShares$132 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.03MShares$101 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.27MShares$46.8 Million1.68% of portfolio
-
American Century Companies Inc Kansas City, MO3.26MShares$46.7 Million0.04% of portfolio
-
River Road Asset Management, LLC3.25MShares$46.5 Million0.95% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $828M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...